DrugCite
Search

ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Enalapril Maleate And Hydrochlorothiazide Adverse Events Reported to the FDA Over Time

How are Enalapril Maleate And Hydrochlorothiazide adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Enalapril Maleate And Hydrochlorothiazide, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Enalapril Maleate And Hydrochlorothiazide is flagged as the suspect drug causing the adverse event.

Most Common Enalapril Maleate And Hydrochlorothiazide Adverse Events Reported to the FDA

What are the most common Enalapril Maleate And Hydrochlorothiazide adverse events reported to the FDA?

Renal Failure Acute
52 (4.55%)
Hyponatraemia
29 (2.54%)
Drug Interaction
28 (2.45%)
Lactic Acidosis
28 (2.45%)
Dehydration
22 (1.92%)
Hypoglycaemia
22 (1.92%)
Fall
16 (1.4%)
Hypotension
16 (1.4%)
Renal Failure
16 (1.4%)
Hypokalaemia
15 (1.31%)
Condition Aggravated
14 (1.22%)
Show More Show More
Diarrhoea
14 (1.22%)
Hyperkalaemia
14 (1.22%)
Malaise
14 (1.22%)
Vomiting
14 (1.22%)
Haemodialysis
13 (1.14%)
Nausea
12 (1.05%)
Anaemia
10 (.87%)
Confusional State
10 (.87%)
Inappropriate Antidiuretic Hormone ...
10 (.87%)
Somnolence
10 (.87%)
Blood Pressure Increased
9 (.79%)
Asthenia
8 (.7%)
General Physical Health Deteriorati...
8 (.7%)
Haemoglobin Decreased
8 (.7%)
Anorexia
7 (.61%)
Blood Creatinine Increased
7 (.61%)
Depressed Level Of Consciousness
7 (.61%)
Dyspnoea
7 (.61%)
Metabolic Acidosis
7 (.61%)
Pancreatitis Acute
7 (.61%)
Arthralgia
6 (.52%)
Gamma-glutamyltransferase Increased
6 (.52%)
Headache
6 (.52%)
Hyperglycaemia
6 (.52%)
Hypertension
6 (.52%)
Intestinal Obstruction
6 (.52%)
Osteonecrosis
6 (.52%)
Renal Failure Chronic
6 (.52%)
Urinary Tract Infection
6 (.52%)
Abnormal Behaviour
5 (.44%)
Blood Bilirubin Increased
5 (.44%)
Blood Potassium Increased
5 (.44%)
Chest Pain
5 (.44%)
Decreased Appetite
5 (.44%)
Disorientation
5 (.44%)
Gastroenteritis
5 (.44%)
Hyperthermia
5 (.44%)
Hypertonia
5 (.44%)
Hypoglycaemic Coma
5 (.44%)
Intentional Overdose
5 (.44%)
International Normalised Ratio Incr...
5 (.44%)
Jaundice
5 (.44%)
Pyrexia
5 (.44%)
Stevens-johnson Syndrome
5 (.44%)
Angioedema
4 (.35%)
Asterixis
4 (.35%)
Blood Potassium Decreased
4 (.35%)
Blood Sodium Decreased
4 (.35%)
Cardiac Failure
4 (.35%)
Cough
4 (.35%)
Cytolytic Hepatitis
4 (.35%)
Diabetes Mellitus
4 (.35%)
Dizziness
4 (.35%)
Drug Ineffective
4 (.35%)
Embolic Stroke
4 (.35%)
Foetor Hepaticus
4 (.35%)
Gastritis Erosive
4 (.35%)
Glycosylated Haemoglobin Increased
4 (.35%)
Haemolytic Anaemia
4 (.35%)
Hyperhidrosis
4 (.35%)
Hypochloraemia
4 (.35%)
Lung Disorder
4 (.35%)
Neutropenia
4 (.35%)
Pancreatic Enzymes Increased
4 (.35%)
Rash Generalised
4 (.35%)
Syncope
4 (.35%)
Anuria
3 (.26%)
Arterial Thrombosis Limb
3 (.26%)
Aspartate Aminotransferase Increase...
3 (.26%)
Back Pain
3 (.26%)
Blister
3 (.26%)
Blood Albumin Decreased
3 (.26%)
Blood Alkaline Phosphatase Increase...
3 (.26%)
Bradycardia
3 (.26%)
Brain Oedema
3 (.26%)
Cardio-respiratory Arrest
3 (.26%)
Catatonia
3 (.26%)
Cholestasis
3 (.26%)
Coma
3 (.26%)
Dermatitis Exfoliative
3 (.26%)
Disease Recurrence
3 (.26%)
Dysgeusia
3 (.26%)
Erythema
3 (.26%)
Gammopathy
3 (.26%)
Hypertensive Crisis
3 (.26%)
Leukocytosis
3 (.26%)
Lichenoid Keratosis
3 (.26%)
Memory Impairment
3 (.26%)
Nodal Arrhythmia
3 (.26%)
Osteoarthritis
3 (.26%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Enalapril Maleate And Hydrochlorothiazide, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Enalapril Maleate And Hydrochlorothiazide is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Enalapril Maleate And Hydrochlorothiazide

What are the most common Enalapril Maleate And Hydrochlorothiazide adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Enalapril Maleate And Hydrochlorothiazide, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Enalapril Maleate And Hydrochlorothiazide is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Enalapril Maleate And Hydrochlorothiazide According to Those Reporting Adverse Events

Why are people taking Enalapril Maleate And Hydrochlorothiazide, according to those reporting adverse events to the FDA?

Hypertension
281
Drug Use For Unknown Indication
32
Product Used For Unknown Indication
28
Essential Hypertension
11
Blood Pressure
5
Blood Pressure Increased
4
Show More Show More
Hypertonia
3
Cardiac Failure Chronic
2
Congestive Cardiomyopathy
2
Cardiac Failure
2
Diphtheria
1
Accidental Exposure
1
Pulmonary Arterial Hypertension
1
Pertussis
1
Atrial Flutter
1
Cardiac Failure Congestive
1
Coronary Artery Disease
1
Ill-defined Disorder
1
Tetanus
1
Interstitial Lung Disease
1
Suicide Attempt
1
Cardiovascular Disorder
1
Arrhythmia
1

Drug Labels

LabelLabelerEffective
Enalapril Maleate And HydrochlorothiazidePhysicians Total Care, Inc.20-NOV-09
Enalapril Maleate And HydrochlorothiazideDr. Reddy's Laboratories Limited 17-FEB-10
Enalapril Maleate And HydrochlorothiazideBryant Ranch Prepack10-MAY-10
Enalapril Maleate And HydrochlorothiazideRebel Distributors Corp20-DEC-10
Enalapril Maleate And HydrochlorothiazideMylan Pharmaceuticals Inc.27-APR-11
Enalapril Maleate And HydrochlorothiazideTaro Pharmaceuticals U.S.A., Inc.29-JUN-12
VasereticValeant Pharmaceuticals North America LLC13-SEP-12
Enalapril Maleate And HydrochlorothiazideApotex Corp.01-OCT-12
Enalapril Maleate And HydrochlorothiazideTeva Pharmaceuticals USA Inc07-MAR-13

Enalapril Maleate And Hydrochlorothiazide Case Reports

What Enalapril Maleate And Hydrochlorothiazide safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Enalapril Maleate And Hydrochlorothiazide. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Enalapril Maleate And Hydrochlorothiazide.